Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2).
Lebwohl MG, Leonardi CL, Mehta NN, Gottlieb AB, Mendelsohn AM, Parno J, Rozzo SJ, Menter A. Lebwohl MG, et al. Among authors: menter a. J Am Acad Dermatol. 2020 Feb;82(2):519-522. doi: 10.1016/j.jaad.2019.09.042. Epub 2019 Sep 26. J Am Acad Dermatol. 2020. PMID: 31563641 Free article. No abstract available.
Psoriasis symposium. Cyclosporine.
Menter A. Menter A. Semin Dermatol. 1992 Dec;11(4 Suppl 1):30-4. Semin Dermatol. 1992. PMID: 1493100 No abstract available.
Guttate psoriasis and vitiligo: anatomic cohabitation.
Menter A, Boyd AS, Silverman AK. Menter A, et al. J Am Acad Dermatol. 1989 Apr;20(4):698-700. doi: 10.1016/s0190-9622(89)80158-6. J Am Acad Dermatol. 1989. PMID: 2715422 No abstract available.
The annual cost of psoriasis.
Sander HM, Morris LF, Phillips CM, Harrison PE, Menter A. Sander HM, et al. Among authors: menter a. J Am Acad Dermatol. 1993 Mar;28(3):422-5. doi: 10.1016/0190-9622(93)70062-x. J Am Acad Dermatol. 1993. PMID: 8445058
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.
Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, Goffe BS, Menter A, Lowe NJ, Krueger G, Brown MJ, Weiner RS, Birkhofer MJ, Warner GL, Berry KK, Linsley PS, Krueger JG, Ochs HD, Kelley SL, Kang S. Abrams JR, et al. Among authors: menter a. J Clin Invest. 1999 May;103(9):1243-52. doi: 10.1172/JCI5857. J Clin Invest. 1999. PMID: 10225967 Free PMC article. Clinical Trial.
Pharmacokinetics and safety of tazarotene.
Menter A. Menter A. J Am Acad Dermatol. 2000 Aug;43(2 Pt 3):S31-5. doi: 10.1067/mjd.2000.108321. J Am Acad Dermatol. 2000. PMID: 10898827 Review.
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?
Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RM. Krueger GG, et al. Among authors: menter a. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):281-5. doi: 10.1067/mjd.2000.106374. J Am Acad Dermatol. 2000. PMID: 10906652
383 results